業績

HOME > 業績 > 2015年

業績

HOME > 業績 > 2015年

2015年

原著論文: 症例報告を含む

1.	Horita N, Yamamoto M, Sato T, Tsukahara T, Nagakura H, Tashiro K, Shibata Y, Watanabe H, Nagai K, Nakashima K, Ushio R, Ikeda M, Sakamaki K, Yoshiyama T, Kaneko T: Sensitivity and specificity of Cobas TaqMan MTB real-time polymerase chain reaction for culture-proven Mycobacterium tuberculosis: meta-analysis of 26999 specimens from 17 Studies. Sci Rep, 5: 18113, 2015.
2.	Masuda M, Sato T, Sakamaki K, Kudo M, Kaneko T, Ishigatsubo Y: The effectiveness of sputum pH analysis in the prediction of response to therapy in patients with pulmonary tuberculosis. PeerJ, 3: e1448, 2015.
3.	Ushio R, Yamamoto M, Shibata Y, Ishii H, Watanabe K, Takahashi R, Sato T, Kudo M, Miyake A, Kaneko T, Ishigatsubo Y: An Autopsy Case Report of Malignant Pleural Mesothelioma with Deciduoid Features. Intern Med, 54: 2915-7, 2015.
4.	Mishina K, Shinkai M, Shimokawaji T, Nagashima A, Hashimoto Y, Inoue Y, Inayama Y, Rubin BK., Ishigatsubo Y, Kaneko T: HO-1 Inhibits IL-13-Induced Goblet Cell Hyperplasia associated with CLCA1 Suppression in Normal Human Bronchial Epithelial Cells. Int Immunopharmacol, 29: 448-53, 2015.
5.	Manabe S, Oshita F, Murakami S, Kondo T, Saito H, Kaneko T, Yamada K: Phase ll Study of Carboplatin and Pemetrexed Followed by Gefitinib for Patients with Advanced Non-Small Cell Lung Cancer Harboring Sensitive EGFR Mutation. J Cancer Ther, 6: 1214-22, 2015.
6.	Horita N, Yamamoto M, Sato T, Tsukahara T, Nagakura H, Tashiro K, Shibata Y, Watanabe H, Nagai K, Inoue M, Nakashima K, Ushio R, Shinkai M, Kudo M, Kaneko T: Topotecan for Relapsed Small-cell Lung Cancer: Systematic Review and Meta-Analysis of 1347 Patients. Sci Rep, 5: 15437, 2015.
7.	Horita N, Otsuka T, Haranaga S, Namkoong H, Miki M, Miyashita N, Higa F, Takahashi H, Yoshida M, Kohno S, Kaneko T: Adjunctive Systemic Corticosteroids for Hospitalized Community-Acquired Pneumonia: Systematic Review and Meta-Analysis 2015 Update. Sci Rep, 5: 14061, 2015.
8.	Horita N, Miyazawa N, Yoshiyama T, Kojima R, Ishigatsubo Y, Kaneko T: Currently Used Low-Dose Pyrazinamide Does Not Increase Liver-Injury in the First Two Months of Tuberculosis Treatment. Intern Med, 54: 2315-20, 2015.
9.	Horita N, Hashimoto S, Miyazawa N, Fujita H, Kojima R, Inoue M, Ueda A, Ishigatsubo YI, Kaneko T: Impact of Corticosteroids on Mortality in Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis. Intern Med, 54: 1473-9, 2015.
10.	Moriyama Y, Horita N, Kudo M, Shinkai M, Fujita H, Yamanaka T, Ishigatsubo Y, Kaneko T: Monocyte nadir is a possible indicator for neutrophil nadir during lung cancer chemotherapy. Clin Respir J, Aug 10, 2015. [Epub ahead of print]
11.	Horita N, Miyazawa N, Tomaru K, Inoue M, Kaneko T: Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis. Respirology, 20: 1153-1159, 2015.
12.	Horita N, Kaneko T: Triple therapy vs. dual bronchodilator therapy for chronic obstructive pulmonary disease: Is it worth the cost? Respir Investig, 53: 173-5, 2015.
13.	Horita N, Kaneko T: Genetic model selection for a case-control study and a meta-analysis. Meta Gene, 22: 1-8, 2015.
14.	Horita N, Kaneko T: Role of combined indacaterol and glycopyrronium bromide (QVA149) for the treatment of COPD in Japan. Int J Chron Obstruct Pulmon Dis, 10: 813-22, 2015.
15.	Horita N, Woo T, Miyazawa N, Kaneko T: Pre-operative chemotherapy for non-small cell lung carcinoma. Transl Lung Cancer Res, 4: 8-14, 2015.
16.	Horita N, Miyazawa N, Tomaru K, Inoue M, Ishigatsubo Y, Kaneko T: Vitamin D binding protein genotype variants and risk of chronic obstructive pulmonary disease: A meta-analysis. Respirology, 20: 219-25, 2015.
17.	Horita N, Miyazawa N, Kojima R, Inoue M, Ishigatsubo Y, Kaneko T: Minimum clinically important difference in diffusing capacity of the lungs for carbon monoxide among patients with severe and very severe chronic obstructive pulmonary disease. COPD, 12: 31-7, 2015.
18.	Hara Y, Shinkai M, Kanoh S, Kawana A, Rubin BK, Matsubara O, Kaneko T: Clinico-pathological analysis referring hemeoxygenase-1 in acute fibrinous and organizing pneumonia patients. Respir Med Case Rep, 14: 53-56, 2015.
19.	Shigemori S, Watanabe T, Kudo K, Ihara M, Nigar S, Yamamoto Y, Oshiro K, Sato T, Kitazawa H, Shimosato T: Oral delivery of Lactococcus 1 lactis that secretes bioactive heme oxygenase-1 alleviates development of acute colitis in mice. Microb Cell Fact, 14: 189, 2015.
20.	Sato T, Shimosato T, Ueda A, Ishigatsubo Y, Klinman DM: Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors. Mol Cancer Ther, 14: 2198-2205, 2015.
21.	Wang Y, Yamamoto Y, Shigemori S, Watanabe T, Oshiro K, Wang X, Wang P, Sato T, Yonekura S, Tanaka S, Kitazawa H, Shimosato T: Inhibitory/Suppressive Oligodeoxynucleotide Nanocapsules as Simple Oral Delivery Devices for Preventing Atopic Dermatitis in Mice. Mol Ther, 23: 297-309, 2015.
22.	Tanabe T, Shimokawaji T, Kanoh S, Rubin BK: Secretory phospholipases A2 are secreted from ciliated cells and increase mucin and eicosanoid secretion from goblet cells. Chest, 147: 1599-609, 2015.
23.	伊藤俊輔, 田代研, 星野昌子, 福田勉, 佐野厚, 金子猛: 左大臀筋転移を認めた悪性胸膜中皮腫の1例. 肺癌, 55: 14-9, 2015.
24.	加藤英明, 宗佐博子, 森雅亮, 金子猛: メトロニダゾール誘発性脳症2例の症例報告および国内32例の文献的考察. 感染症学雑誌, 89: 559-66, 2015.

総説

1.	金子猛: 呼吸器疾患治療の標的分子「COPD」. 呼吸と循環, 63: 298-303, 2015.
2.	金子猛: 【特集：COPDと間質性肺炎の最新動向】COPD治療と長期管理の新たな展開. 医学と薬学, 72: 1009-16, 2015.
3.	金子猛: COPD（慢性閉塞性肺疾患）; 内科医の診断と治療の向上を目指して　トピックスⅢ COPD病態・治療「併存症」. 日本内科学会雑誌, 104: 1089-97, 2015.
4.	金子　猛: 座談会「COPDにおける肺の破壊と再生～日本発の研究をより深く知る～」. COPD Selected Papers, 6: 8-18, 2015.
5.	金子猛, 築地淳: ドクターQ&A　正しい知識で予防と受診「肺炎」. ドクターズアイ, 10: 31-6, 2015.
6.	金子猛, 築地淳: ドクターQ&A　正しい知識で予防と受診「肺炎」. セルフドクター, 19: 28-33, 2015.
7.	金子猛: 健康対談（ニュースの達人・鳥越俊太郎氏）「日頃から肺炎予防を考え実践することが重要」. 文藝春秋11月号, 93, 2015.
8.	坪井正博, 鈴木健司, 新海正晴, 岡田守人, 佐野裕子, 青景圭樹: 術後合併症マネージメント低肺機能患者における呼吸器外科周術期管理（解説）. Medical Torch,11(1),38-41, 2015.

著書

1.	金子猛: 今日の治療指針2015「クラミジア（クラミドフィラ）・ニューモニエ感染症」.医学書院, 241-3, 2015.
2.	金子猛: 今日の治療指針2015「慢性閉塞性肺疾患（COPD）」. 医学書院, 310-5, 2015.
3.	金子猛: 今日の診断指針第7版「気胸」. 医学書院, 1051-4, 2015.
4.	山本昌樹, 金子猛: 新呼吸器専門医テキスト「体位ドレナージ療法」. 南江堂, 248-50, 2015.
5.	新海正晴: 生涯教育のためのセルフトレーニング問題と解説第３集「感染症」. 一般社団法人日本内科学会　専門医部会, 2015.
6.	新海正晴: 一発診断！一目瞭然！「特徴的な胸水から考えられる疾患は何か」. 一般社団法人日本内科学会　専門医部会, 21, 77-8, 2015.

シンポジウム・教育講演等

1.	金子猛, 新海正晴: 喘息・COPDにおける気道系・血管系のリモデリングの相違点と類似点. 第55回日本呼吸器学会学術講演会, 東京, 2015, 4.
2.	金子猛: 日本呼吸器学会の学術活動戦略の展望. 第55回日本呼吸器学会学術講演会, 東京, 2015, 4.
3.	新海正晴: 包括的気管支喘息治療. 第55回日本呼吸器学会学術講演会, 東京, 2015, 4.
4.	新海正晴: 在宅酸素濃縮装置の現状と将来展望. 第55回日本呼吸器学会学術講演会, 東京, 2015, 4.
5.	新海正晴: COPDの病態に対応した薬物療法の課題. 第36回生涯教育公演, 東京, 2015, 4.
6.	金子猛: 第2回総合アレルギー講習会～Total Allergistをめざして～　バリア機能の破綻と喘息. 日本アレルギー学会, 横浜, 2015, 12.